StockData
Opus Genetics, Inc. logo

Opus Genetics, Inc. (IRD) stock

IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$4.05+0.01 (+0.25%)

Close on Nov 17, 2026Market cap $336.94MP/E –Yield –

Opus Genetics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Opus Genetics's operating income for the twelve months ending Jun 30, 2026 was -$50.61M. For fiscal 2025 it was -$38.60M. The highest annual figure on record is $18.23M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$38.60M–
FY2024Dec 31, 2024-$62.07M–
FY2023Dec 31, 2023-$10.56M-158.0%
FY2022Dec 31, 2022$18.23M–
FY2021Dec 31, 2021-$22.71M–
FY2020Dec 31, 2020-$19.97M–
FY2019Dec 31, 2019-$4.19M–
FY2018Dec 31, 2018-$20.54M–
FY2017Dec 31, 2017-$17.35M–
FY2016Dec 31, 2016-$16.41M–
FY2015Dec 31, 2015-$18.26M–
FY2014Dec 31, 2014-$13.27M–
FY2013Dec 31, 2013-$7.98M–
FY2012Dec 31, 2012-$6.58M–
FY2011Dec 31, 2011-$16.13M–
FY2010Dec 31, 2010-$10.31M–
FY2009Dec 31, 2009-$6.47M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$16.48M–
Q1 FY2026Mar 31, 2026-$14.36M–
Q4 FY2025Dec 31, 2025-$11.45M–
Q3 FY2025Sep 30, 2025-$8.31M–
Q2 FY2025Jun 30, 2025-$8.91M–
Q1 FY2025Mar 31, 2025-$9.93M–
Q4 FY2024Dec 31, 2024-$38.03M–
Q3 FY2024Sep 30, 2024-$8.01M-225.4%
Q2 FY2024Jun 30, 2024-$8.33M–
Q1 FY2024Mar 31, 2024-$7.71M–
Q4 FY2023Dec 31, 2023-$5.43M-115.9%
Q3 FY2023Sep 30, 2023$6.39M–
Q2 FY2023Jun 30, 2023-$5.39M–
Q1 FY2023Mar 31, 2023-$6.13M–
Q4 FY2022Dec 31, 2022$34.21M–
Q3 FY2022Sep 30, 2022-$4.54M–
Q2 FY2022Jun 30, 2022-$4.94M–
Q1 FY2022Mar 31, 2022-$6.51M–
Q4 FY2021Dec 31, 2021-$6.15M–
Q3 FY2021Sep 30, 2021-$4.23M–
Q2 FY2021Jun 30, 2021-$7.14M–
Q1 FY2021Mar 31, 2021-$5.19M–
Q4 FY2020Dec 31, 2020-$14.02M-379.7%
Q3 FY2020Sep 30, 2020-$1.95M–
Q2 FY2020Jun 30, 2020-$1.26M–
Q1 FY2020Mar 31, 2020-$2.74M–
Q4 FY2019Dec 31, 2019$5.01M–
Q3 FY2019Sep 30, 2019-$2.28M–
Q2 FY2019Jun 30, 2019-$2.99M–
Q1 FY2019Mar 31, 2019-$3.94M–
Q4 FY2018Dec 31, 2018-$4.97M–
Q3 FY2018Sep 30, 2018-$4.68M–
Q2 FY2018Jun 30, 2018-$5.00M–
Q1 FY2018Mar 31, 2018-$5.89M–
Q4 FY2017Dec 31, 2017-$4.90M–
Q3 FY2017Sep 30, 2017-$4.22M–
Q2 FY2017Jun 30, 2017-$4.28M–
Q1 FY2017Mar 31, 2017-$3.95M–
Q4 FY2016Dec 31, 2016-$3.92M–
Q3 FY2016Sep 30, 2016-$3.72M–

More Opus Genetics figures

See a number that looks wrong?